Xiamen Kingdomway Group Co. Class A 002626

SZSE · China · Health Technology

CNY 16.13+0.17 (+1.07%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Xiamen Kingdomway Group Co. Class A 002626

SZSE · China · Health Technology

CNY 16.13+0.17 (+1.07%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-9.18% · 6MFull-screen chart

Open CNY 16.00High CNY 16.23Low CNY 15.96Close CNY 16.13Volume 2.38M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 15.96
Day range: CNY 15.96 – CNY 16.23
52-week range: CNY 12.90 – CNY 22.44
Volume: 2.38M
Market cap: CNY 9.73B
P/E (TTM): 39.3
Dividend yield (annualized): 2.48%
Next earnings date: 2026-10-26
Avg. volume (1Y): 6.95M

Performance

1 week

-3.87%

1 month

-1.89%

3 months

+13.91%

6 months

-4.34%

Year to date

-17.06%

1 year

-17.64%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: China
Exchange: SZSE
Shares outstanding: 603.32M
Employees: 2,184
ISIN: CNE1000018X4
Beta: 0.98

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJan 07, 2026

Doctor's Best Celebrates FDA Decision on NMN Supplements, Relaunches Product Line

Doctor's Best, a leading nutritional supplement company, announces that its parent company, Xiamen Kingdomway Group, has received a New Dietary Ingredient (NDI) letter from the Food and Drug Administration (FDA) for its beta-Nicotinamide Mononucleotide (NMN) supplements. This FDA action permits the sale of NMN products by Kingdomway and marks a pivotal moment for the company and the broader supplement market.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.